Discover 3,600 paid clinical trials in Glendale, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,600
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Los Angeles CA, Beverly Hills CA, Santa Monica CA,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT06943755
Phase 2, Phase 3, Recruiting
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Los Angeles CA, Bakersfield CA, Surprise AZ, Peoria AZ,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06992427
Phase 3, Recruiting
Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers
for
NSCLC
Location: Los Angeles CA, Orange CA, Davis CA, Seattle WA,
Sponsor: Lung Cancer Mutation Consortium
Sex: All
Age: 0+
Code: NCT04712877
Recruiting
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Location: Los Angeles CA, San Antonio TX, Houston TX, St Louis MO,
Sponsor: Angiex, Inc.
Sex: All
Age: 18+
Code: NCT06440005
Phase 1, Recruiting
Confronting Cancer as a Community
for
Colorectal Carcinoma
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT06063928
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
for
Primary Immune Thrombocytopenia (ITP)
Location: Los Angeles CA, Oceanside CA, Phoenix AZ, Aurora CO,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT06544499
Phase 3, Recruiting
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
for
Germ Cell Tumor
Location: Los Angeles CA, Downey CA, Long Beach CA, Loma Linda CA,
Sponsor: University of Sydney
Sex: All
Age: 11 - 50
Code: NCT02582697
Phase 3, Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
for
cGVHD
Location: Los Angeles CA, Duarte CA, Phoenix AZ,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT05919511
Recruiting
A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Los Angeles CA, Seattle WA, Houston TX, Madison WI,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06625593
Phase 1, Recruiting
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
for
Gastric or Gastroesophageal Junction Adenocarcinoma,
Location: Los Angeles CA, Duarte CA, Denver CO, Houston TX,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05482893
Phase 1, Phase 2, Recruiting
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Location: Los Angeles CA, Houston TX, Grand Rapids MI, Toledo OH,
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Sex: All
Age: 18+
Code: NCT06095583
Phase 3, Recruiting
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations